Rotavirus induces a biphasic enterotoxic and cytotoxic response in human-derived intestinal enterocytes, which is inhibited by human immunoglobulins

Journal of Infectious Diseases

Volumn 200, Issue 5, 2009, Pages 813-819

  De Marco, Giulio ^a   Bracale, Ileana ^a   Buccigrossi, Vittoria ^a   Bruzzese, Eugenia ^a   Canani, Roberto Berni ^a   Polito, Gaetano ^a   Ruggeri, Franco Maria ^b   Guarino, Alfredo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNOGLOBULIN; ROTAVIRUS NONSTRUCTURAL PROTEIN 4; CHLORIDE; GLYCOPROTEIN; IMMUNOGLOBULIN; ION; NS28 PROTEIN, ROTAVIRUS; TOXIN; VIRUS ANTIBODY; VIRUS PROTEIN;

ARTICLE; CELL DAMAGE; CELL TRANSPORT; CHLORIDE TRANSPORT; CONTROLLED STUDY; DIARRHEA; HUMAN; HUMAN CELL; INTESTINE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA VIRUS INFECTION; ROTAVIRUS; VIRUS REPLICATION; CELL DEATH; CELL STRAIN CACO 2; CELL SURVIVAL; IMMUNOLOGY; ION TRANSPORT; METABOLISM; PATHOGENICITY; PERMEABILITY; PHYSIOLOGY; SERODIAGNOSIS; VIROLOGY;

ANTIBODIES, VIRAL; CACO-2 CELLS; CELL DEATH; CELL SURVIVAL; CHLORIDES; ENTEROCYTES; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULINS; ION TRANSPORT; IONS; NEUTRALIZATION TESTS; PERMEABILITY; ROTAVIRUS; TOXINS, BIOLOGICAL; VIRAL NONSTRUCTURAL PROTEINS;

EID: 70349309784     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/605125     Document Type: Article

References (40)

1. Kosek M, Bern C, Guerrant RL The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 2003;81:197-204.
2. Glass RI, Kilgore PE, Holman RC, et al. The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of the disease burden. J Infect Dis 1996; 176(Suppl 1):S5-11.
3. 3. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23-33. (Pubitemid 43048948)
4. 4. Ruiz-Palacios GM, Pérez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22. (Pubitemid 43048947)
5. 5. Albano F, Bruzzese E, Bella A, et al. Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study. Eur J Pediatr 2007; 166:241-247 (Pubitemid 46352517)
6. Lundgren O, Svensson L. Pathogenesis of Rotavirus diarrhea. Microbes Infect 2001;3:1145-1156
7. Estes MK, Kang G, Zeng CQY, Crawford SE, Ciarlet M. Pathogenesis of rotavirus gastroenteritis. 2001. Novartis Found Symp 2001; 238: 82-100.
8. Halls IH, Ruck B, Bishop R, Davidson G. Infantile enteritis; morphogenesis and morphology. J Virol 1975; 16:937-943
9. Davidson GP, Barnes GL. Structural and functional abnormalities of the small intestine in infants and young children with rotavirus enteritis. Acta Paediatr Scand 1979;68:181-186
10. 10. Reynolds D, Hall G, Debney T, Parsons K. Pathology of natural rotavirus infection in clinically normal calves. Res Vet Sei 1985; 38:264-269 (Pubitemid 15091855)
11. Boshuizen JA. Changes in small intestinal homeostasis, morphology, and gene expression during rotavirus infection of infant mice. J Virol 2003;77:13005-13016
12. 12. Ward LA, Rosen BI, Yuan L, Saif L. Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. J Gen Virol 1996;77:1431-1441 (Pubitemid 26248656)
13. Collins JE, Benfield DA, Duimstra JR. Comparative virulence of two porcine group-A rotavirus isolates in gnotobiotic pigs. Am J Vet Res 1989;50:827-835
14. McAdaragh JP, Bergeland ME, Meyer RC, et al. Pathogenesis of rotaviral enteritis in gnotobiotic pigs: a microscopic study. Am J Vet Res 1980;41: 1572-1581
15. 15. Ball JM, Tian P, Zeng CQ-Y, Morris A, Estes MK. Age-dependent diarrhoea is induced by a viral nonstructural glycoprotein. Science 1996;272:101-104 (Pubitemid 26110759)
16. 16. Tian P, Hu Y, Shilling WP, Lindsay DA, Eiden J, Estes MK. The nonstructural glycoprotein of rotavirus affects intracellular calcium levels. J Virol 1994;68:251-257 (Pubitemid 24974628)
17. 17. Au KS, Chan WK, Burns JW, Estes MK. Receptor activity of rotavirus nonstructural glycoprotein NS28. J Virol 1989; 63:4553-4562 (Pubitemid 19257829)
18. Tian P, Estes MK, Hu Y, Ball JM, Zeng CQ, Shilling WP. The rotavirus nonstructural glycoprotein NSP4 mobilzes Ca2+ from the endoplasmic reticulum. J Virol 1995;69:5763-5772
19. 19. Zhang M, Zeng CQ, Dong Y, et al. Mutations in rotavirus nonstructural glycoprotein NSP4 are associated with altered virus virulence. J Virol 1998; 72:3666-3672 (Pubitemid 28188663)
20. Lorrot M, Vasseur M. How do the rotavirus NSP4 and bacterial enterotoxins lead differently to diarrhea? Virol J 2007; 4:31.
21. Svensson L, Finlay BB, Buss D, von Bonsdorff CH, Greenberg HB. Symmetric infection of rotavirus on polarized human intestinal epithelial (Caco-2) cells. J Virol 1991;65:4190-4197
22. 22. Guarino A, Casola A, Bruzzese E, Saini M, Nitsh L, Rubino A. Human serum immunoglobulin counteracts rotaviral infection in Caco-2 cells. Pediatr Res 1996;40:881-887 (Pubitemid 26404202)
23. Guarino A, Guandalini S, Albano F, Mascia A, De Ritis G, Rubino A. Enteral immunoglobulins for treatment of protracted rotaviral diarrea. Pediatr Infect Dis J 1991; 10:612-614
24. 24. Guarino A, Berni Canani R, Russo S, et al. Oral immunoglobulins for treatment of acute rotaviral gastroenteritis. Pediatrics 1994;93:12-16 (Pubitemid 24012122)
25. Guarino A, Albano F, Berni Canani R, Bruzzese E. HIV, fatal rotavirus infection, and treatment options. Lancet 2002; 359:74.
26. Guarino A, Berni Canani R, Casola A, et al. Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells. J Infect Dis 1995; 171:976-983
27. 27. Estes MK, Graham DY, Gerba CP, Smith EM. Simian rotavirus SA11 replication in cell culture. J Virol 1979;31:810-815 (Pubitemid 10235267)
28. Kitamoto N, Ramig RF, Matson DO, Estes MK. Comparative growth of different rotavirus strains in different cells (MA 104, Hep G2, Caco2). Virology 1991; 184:729-737
29. Wyatt RG, Greenberg HB, James WD, et al. Definition of human rotavirus by plaque reduction assay. Infect Immun 1982;37:110-115
30. - fluxes and short.circuit current. Am J Physiol 1971; 220:1388-1398
31. Guarino A, Bisceglia M, Berni Canani R, et al. Enterotoxic effect of the vacuolating toxin produced by Helicobacter pylori in Caco-2 cells. J Infect Dis 1998; 178:1373-1378
32. 32. Canani RB, Cirillo P, Mallardo G, et al. Effects of HIV-1 Tat protein on ion secretion and cell proliferation in human intestinal epithelial cells. Gastroenterology 2003; 124:368-376 (Pubitemid 36169254)
33. Doggrell S, Hoey A, Brown L. Ion channel modulators as potential positive inotropic compound for treatment of heart failure. Clin Exp Pharmacol Physiol 1994;21:833-843
34. 34. Lundgren O, Peregrin AT, Persson K, Kordasti S, Uhnoo I, Svensson L. Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science 2000; 287:491-495 (Pubitemid 33595258)
35. + in the replication and pathogenesis of rotavirus and other Viral infections. Cell Calcium 2000;28:137-149
36. 36. Catto-Smith AG, Emselle S, Bishop RF. Changes in macromolecular transport appear early in Caco-2 cells infected with a human rotavirus. Scand J Gastroenterol 2008;43:314-322 (Pubitemid 351238366)
37. 37. Schwartz-Cornil I, Benureau Y, Greenberg H, Hendrickson BA, Cohen J. Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins. J Virol 2002;76:8110-8117 (Pubitemid 34809065)
38. Franco MA, Angel J, Greenberg HB. Immunity and correlates of protection for rotavirus vaccines. Vaccine 2006;24:2718-2731
39. 39. Jiang B, Gentsch JR, Glass RI. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis 2002;34:1351-1361 (Pubitemid 34507945)
40. Hyser JM, Estes MK. Rotavirus vaccines and pathogenesis: 2008. Curr Opin Gastroenterol 2009; 25:36-43.